AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...
European shares fell on Friday, dragged down by disappointing earnings, concerns about the impact of U.S. President-elect Donald Trump's policies, and a jump in Treasury yields. Investors were also ...
I-Mab is a U.S.-based global biotechnology company focused on developing innovative immunotherapies for cancer treatment, ...
EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...
FRANKFURT: European shares slipped on Friday, weighed down by disappointing earnings, concerns about the impact of ...